CE Pricing / Flex Credit

Save with tiered CE Pricing
Starts at $9.98 per contact hour
Min. Hours $$/Hr
4 hours $8.98
8 hours $7.98
12 hours $6.98
20 hours $5.98
30 hours $4.98

Alzheimers Disease: Mysteries and Possibilities

4.0 Contact Hours / 0.40 AOTA CEUs
Target Audience: Nurses, healthcare professionals, and interested individuals
Purpose/Goal: The outcome of this course is for the learner to describe the signs and symptoms of AD, methods of diagnosis, aspects of care and treatment, caregiver issues, integrative health considerations, and implications for the future of Alzheimer's disease and various other types of dementia.
$35.92
Add to Cart

Alzheimer’s disease (AD) is a condition in which the concept of loss is profound and central—the loss of one’s memories, independence, ability to recognize loved ones, and dignity. Often referred to as “the long goodbye,” AD is the most common type of dementia, affecting millions of Americans. It is responsible for billions of dollars annually in healthcare costs. However, new research is providing hope for those with Alzheimer’s disease as well as for their families and caregivers.

Upon completion of the course, you will be able to do the following:

  • Describe the incidence and impact of Alzheimer's disease on national and global health.
  • Identify the key milestones in the history of Alzheimer's disease.
  • Explain the aspects of brain anatomy and physiology as it relates to Alzheimer's disease.
  • Differentiate between normal brain changes that occur with aging and those changes associated with Alzheimer's disease.
  • Explain the causes of Alzheimer's disease.
  • State the effects of Alzheimer's disease on the various areas of the brain.
  • Identify risk factors associated with Alzheimer's disease.
  • Explain the stages of Alzheimer's disease.
  • Differentiate between Alzheimer's disease and depression.
  • Identify characteristics of common types of dementia.
  • Explain key methods used to diagnose Alzheimer's disease.
  • Describe basic elements of care for the person with Alzheimer's disease.
  • Explain methods to effectively manage behavior in individuals with Alzheimer's disease.
  • Identify possible integrative therapies that may affect the development or behaviors associated with Alzheimer's disease.
  • Identify caregiver issues related to Alzheimer's disease.
  • Describe possible stress management options for caregivers.
  • State current research initiatives and findings in Alzheimer's disease.

Jenny couldn’t really say when it all began. She just knew that lately she was having trouble remembering where she put her car keys and glasses, and she was even having trouble recognizing some of her friends. At this very moment, she was trying to remember the name of her youngest child, but as much as she tried, she couldn’t. For that matter, she was having trouble remembering what she ate last night and what movie she saw with her friend earlier in the day. Jennie knew that something wasn’t quite right in her mind but she attributed it to being retired and to the stress of helping to care for one of her children who had been sick during the past several months. Even her friends had begun to comment on her forgetfulness. She was frightened. Did she have Alzheimer’s disease?

Called one of the most significant health and social crises of the 21st century, Alzheimer’s disease (AD) prevents many older adults and their families from enjoying their “Golden Years.” The World Alzheimer Report 2016 (Alzheimer’s Disease International, 2016) states that Alzheimer’s disease and other dementias present the capacity for social and economic disruptions for which the world is woefully unprepared.

The population of those over age 65 years is expected to double in size to about 72 million people between 2010 and 2035, and the age group of 85 years and older is now the fastest growing segment of the population. With the number of people with AD doubling for every 5-year age interval beyond age 65, many of us will have at least one relative afflicted with Alzheimer’s disease (National Institute on Aging [NIA], 2017). 

According to Alzheimer’s Disease Research (2010):

  • If dementia were a country, it would be the world’s 18th largest economy.
  • If dementia were a company, its revenues would be the largest company in the United States, exceeding Walmart (U.S. $414 billion) and Exxon Mobile (U.S. $311 billion).

Complete the course post exam (CE Test) with a score of 80% or greater. Complete all fields of the course evaluation form. Certificate of Completion is provided once the course post exam is passed per criteria above.

  • American Board of Managed Care Nursing
    The American Board of Managed Care Nursing recognizes all of ALLEGRA Learning Solutions' ANCC accredited courses for continuing education credit for Certified Managed Care Nurses (CMCNs).
  • ANCC - American Nurses Credentialing Center
    ALLEGRA Learning Solutions, LLC is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
  • AOTA - American Occupational Therapy Association
    ALLEGRA Learning Solutions, LLC, is an approved provider of continuing education for occupational therapists by the American Occupational Therapy Association. Approved Provider # 3166
  • ASWB - Association of Social Work Boards
    This course is approved by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program to be offered by ALLEGRA Learning Solutions, LLC as an individual course. Individual courses, not providers, are approved at the course level. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. ACE course approval period: 04/22/2021-04/22/2024. Social workers completing this course receive the specified distance learning continuing education credits.
  • California Board of Behavioral Sciences
    California Board of Behavioral Sciences Provider Number PCE 1564. Course meets the qualifications for the stated hours of continuing education credit for MFTs and/or LCSWs as required by the California Board of Behavioral Sciences.
  • California Board of Registered Nursing
    ALLEGRA Learning Solutions is approved by the California Board of Registered Nursing, Provider # CEP 14693 for the number of hours stated.
  • California Department of Health, Aid, and Technician Certification Section
    The California Department of Health, Aid, and Technician Certification Section accepts continuing education offered by CA-BRN approved providers.
  • District of Columbia Board of Nursing
    ALLEGRA Learning Solutions (CE Provider # 50-12076) submits all continuing education records to CE BROKER after successful completion.
  • Florida Board of Nursing
    ALLEGRA Learning Solutions, LLC is accredited as a provider of continuing education by the Florida Board of nursing (CE Provider # 50-12076). Courses are automatically submitted to CE Broker.
  • Florida Board of Nursing - Certified Nursing Assistants
    ALLEGRA Learning Solutions (CE Broker Provider # 50-12076) submits all continuing education records to CE Broker after successful completion.
  • Florida Board of Respiratory Care
    ALLEGRA Learning Solutions, LLC is accredited as a provider of continuing education by the Florida Board of Respiratory Care
  • Florida Council of Dietetics and Nutrition
    ALLEGRA Learning Solutions, LLC is accredited as a provider of continuing education by the Florida Council of Dietetitics and Nutrition
  • NCBTMB -National Certification Board for Therapeutic Massage & Bodywork
    ALLEGRA Learning Solutions, LLC is approved by the National Certification Board for Therapeutic Massage & Bodywork (NCBTMB) as a continuing education Approved Provider. Provider Number 451562-11.
  • Florida Board of Massage Therapists
    ALLEGRA Learning Solutions, LLC is accredited as a provider of continuing education by the Florida Board of Massage Therapists
  • Florida Council of Licensed Midwifery
    ALLEGRA Learning Solutions, LLC is accredited as a provider of continuing education by the Florida Council of Licensed Midwifery
  • NAADAC - The National Association of Alcohol and Drug Abuse Counselors
    This course has been approved by ALLEGRA Learning Solutions, LLC, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #813, ALLEGRA Learning Solutions, LLC is responsible for all aspects of their programming.
AOTA CEUs:

0.4

Practice Level:

Intermediate

Content Focus:

Professional Issues

Course Expires:

July 11, 2026

Instructor(s):
  • Cyndie Koopsen, RN, BSN, MBA, HNB-BC, RN-BC, HWNC-BC
  • Caroline Young, MPH
Jurisdictional Requirements:

Continuing education (CE) licensing requirements vary by jurisdiction, are not well defined, and may change. These CE requirements may vary in terms of the number of hours required to the types of courses that must be taken. ALLEGRA Learning Solutions, LLC recommends you contact your licensing board or accrediting organization for the latest continuing education requirements of your state or territory. Compliance with CE requirements is the responsibility of the individual health care provider. Health care providers must understand the CE requirements in their jurisdictions, and be sure they are up-to-date on any rule changes that affect their license. For further information, please see our Accreditation Information.

Accommodations for Disabilities:

Every effort will be made to accommodate your special needs. To request accommodations, please contact us.

Conflicts of Interest and Relevant Financial Relationships:

The authors/planning committee members have no conflicts of interests or relevant financial relationships to declare relevant to this activity.

Commercial Support:

No commercial support has been received for this activity.

Non-endorsement of products:

Accreditation refers to recognition of continuing nursing education only and does not imply ALLEGRA Learning Solutions, LLC approval or endorsement of any commercial product.

Off-label Use of Products:

None of the authors intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Cart

0.0
Hrs